The United Nations Office at Geneva
Multimedia Newsroom
STORYLINE
Injectable HIV medicines deal to provide access to generic lifesaver in developing nations
A landmark agreement has been reached allowing for the production of low-cost, injectable HIV medicines in some 90 developing countries where more the majority of infections occur, UNITAID said on Friday.
Selected manufacturers will be able to develop, manufacture and supply lower-cost generic versions of long-acting Cabotegravir (CAB-LA), in line with a deal reached with pharmaceutical firm ViiV Healthcare (ViiV).
“The Medicines Patent Pool, a structure created and largely funded by UNITAID, has reached a voluntary licensing agreement for patents relating to Cabotegravir long-acting, an injectable form of HIV prevention, or PrEP, to generic formulations of the product in least-developed, low-income, lower-middle income and sub-Saharan African countries,” said UNITAID spokesperson Hervé Verhoosel.
The deal is significant because Cabotegravir injections are only needed once every few months. Increasing its supply at a cost that is affordable to low-income countries could help to overcome the stigma that’s associated with taking daily HIV pills - and the burden of having to remember to take them.
“In the 90 countries that we are talking about, 80 countries are royalty-free, meaning that ViiV won’t ask for any royalty on the product and for 10 of those countries, ViiV is asking for a smaller-than-usual royalty,” Mr. Verhoosel explained.
The agreement comes after UNITAID-led discussions began in May this year with ViiV, a subsidiary of pharma giant GlaxoSmithkline. It is only seven months since Cabotegravir LA received regulatory approval.
But the process of selecting the companies that will develop, manufacture and supply generic versions of Cabotegravir will take much longer.
“This product will not be there for everybody, that’s first for people who are there the most at risk,” said Mr. Verhoosel, who noted that the cost of the medicine in the US when it comes onstream there “really soon”, was likely to be around $20,000. “That’s a lot of money; that’s why that product cannot be used in low and middle-income countries.”
According to UNITAID, the deal offers the possibility of making the injectable prophylactic medicine available in 90 countries where more than 70 per cent of all new HIV infections occurred in 2020.
Up to three drug manufacturers will be licensed to develop the product on a generic basis to avoid supply and distribution issues. “That’s done in a way that we’re sure (that) one, it’s easy for logistics, two…availability, and three, of course, that it will help to bring the cost of the generic version down”, said Mr. Verhoosel.
ends
STORY: Injectable HIV Prevention Medicines Deal - UNITAID
TRT: 02’05”
SOURCE: UNTV CH
RESTRICTIONS: NONE
LANGUAGE: ENGLISH/NATS
ASPECT RATIO: 16:9
DATELINE: Friday 29 July 2022, GENEVA, SWITZERLAND
SHOTLIST
- Medium shot, UN Geneva flag alley.
- Wide shot, press room with panel of speakers, journalists, TV camera on tripod.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “The Medicines Patent Pool, a structure created and largely funded by UNITAID, has reached a voluntary licensing agreement for patents relating to cabotegravir long-acting, an injectable form of HIV prevention, or PrEP, to generic formulations of the product in least-developed, low-income, lower-middle income and sub-Saharan African countries.”
- Medium shot, lateral, podium speakers.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “In the 90 countries that we are talking about, 80 countries are royalty-free, meaning that ViiV (ViiV Healthcare) don’t ask any royalty on the product and for 10 of those countries ViiV is asking for a smaller-than-usual royalty.”
- Wide shot, journalists, TV camera, light panel.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “This product will not be there for everybody, that’s first for people who are there the most at risk. That’s a product that’s available in the US, and the price of that product for one year in the US for example is approximately 20,000 US dollars, and that’s a lot of money; that’s why that product cannot be used in low and middle-income countries.”
- Medium shot, journalists seated at tables, TV camera.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “This licence will actually give the option to three different generic manufacturers to develop the product on a generic base. That means that the price that those companies will have we don’t know yet, but that will not only be one company, that will be three different companies and that’s done in a way that we’re sure one, that it’s easy for logistics, two, that ensuring availability, and three, of course, that it will help to bring the cost of the generic version down.”
- Medium shot, journalists.
- Wide shot, journalists, TV camera and light panel.
- Medium shot, journalist.
- Medium shot, journalists, side shot.
Similar Stories
1
1
1
Edited News | OHCHR , UNOG
A UN Human Rights Office report released today on Israel’s settlement expansion in the occupied West Bank.
1
1
1
Edited News | OHCHR , UNOG
UN Human Rights Spokesperson Thameen Al-Kheetan made the following remarks on Tuesday concerning the deadly blast at a drug rehabilitation centre in Kabul:
1
1
1
Edited News | OHCHR , UNOG
UN Human Rights Spokesperson Thameen Al-Kheetan made the following remarks on the impact of Israeli airstrikes on Lebanon.
1
1
1
Edited News | OCHA , OHCHR , WFP
Middle East war may deepen global hunger; mass displacement, rights violations on the rise
The Middle East war could cause the worst disruption to humanitarian work since COVID, the UN World Food Programme (WFP) warned on Tuesday.
2
1
2
Statements , Conferences , Edited News | HRC
The UN’s top human rights forum gathered in Geneva on Monday, where Member States highlighted the growing civilian toll of war in the Middle East, sparked by Israeli and U.S. bombing of Iran, counter-strikes by Tehran against Gulf states and Israeli shelling of Hezbollah targets in Lebanon in response to attacks by the armed group.
1
1
1
Edited News | UNIFIL , UNFPA , IOM , UNHCR
As the UN Secretary-General touched down in Beirut on Friday in solidarity with the people of Lebanon, UN agencies highlighted the dangers for civilians and particularly pregnant women and migrant workers, amid ongoing airstrikes and rocket fire between Hezbollah fighters and Israel.
2
1
2
Press Conferences , Edited News | HRC
Russia’s deportations of Ukrainian children amount to crimes against humanity: independent UN rights probe
Scores of Ukrainian children are still missing after being deported far and wide across Russia and occupied territories while their families continue to search for them, human rights investigators said on Thursday.
2
1
2
Edited News , Press Conferences | OCHA
The UN’s emergency relief chief on Wednesday condemned the “$1 billion-a-day” cost of the war roiling the Middle East, at a time of severe cuts to the global body’s humanitarian work in emergencies and “soaring” needs.
1
1
1
Edited News | OHCHR , WHO , UNHCR , UNICEF , WFP
Middle East war: UN warns of ‘toxic rain’ danger from oil depot strikes as mass displacement, aid supply shocks spread
Toxic “black rain” linked to strikes on oil depots, mass displacement and continuing disruption to humanitarian supply chains are upending lives across the Middle East and beyond after 10 days of war in the region, UN humanitarians said on Tuesday.
1
1
1
Edited News | OHCHR , UNOG
UN Human Rights Spokesperson Ravina Shamdasani on Friday made the following remarks on Israel’s military ground incursions and displacement orders in Lebanon.
1
1
1
Edited News | OHCHR , IOM , WHO
The escalating war in the Middle East has heightened growing concerns about further civilian suffering and displacement in the region and far beyond, UN agencies said on Friday.
2
1
2
Press Conferences , Edited News | OHCHR
UN Human Rights chief Volker Türk made the following remarks at a press stake out on the current situation in the Middle East.
“The crisis sparked in the Middle East one week ago following US and Israeli attacks on Iran, and Iran’s counterattacks, has been spreading like wildfire. It is causing significant damage in Iran, Israel and at least a dozen other countries, mostly in the Gulf, with risks of major economic and environmental ramifications across the world,” he said.